Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
39.30
-0.20 (-0.51%)
At close: Feb 6, 2026
100.51%
Market Cap458.99M +144.1%
Revenue (ttm)n/a
Net Income-25.52M
EPSn/a
Shares Out1.17B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,495,235
Average Volume9,298,546
Open39.50
Previous Close39.50
Day's Range38.00 - 40.90
52-Week Range14.40 - 60.90
Beta0.73
RSI45.91
Earnings DateMar 30, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 37
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements